资讯

AFN10 小时
BiomEdit raises $18.4m Series B to expand designer probiotics platform
BiomEdit has raised an $18.4m Series B round and is gearing up to launch its first product, a designer probiotic to tackle ...
360Dx8 小时
Diasorin, Roche, Abbott, Others Gain FDA Clearances in June
The US Food and Drug Administration granted clearances for infectious disease tests, digital pathology software, and hematology analyzers, among other in vitro diagnostic technologies.